Sun Pharma: An update on generic Protonix® litigation |
Sun Pharmaceutical Industries Ltd. announced that a jury returned a verdict in the patent litigation over generic Protonix® currently on in the U.S. District Court for the District of New Jersey. The jury determined that Nycomed's U.S. Patent No. 4,758,579 is not invalid.
The Court has reserved decision on the issue of the effect to be given to the jury's determinations relating to the obviousness-type double patenting defenses, which as the Company has argued, is to be decided by the Court. Pantoprazole Sodium DR Tablets from a subsidiary of Sun Pharma are the AB-rated generic equivalent of Wyeth's Protonix® DR Tablets.
|
|
